Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to initiate its nPulse Cardiac Catheter Ablation System study for the treatment of ...

Understanding Varicose Veins Varicose veins arise from a chronic circulatory disorder called chronic venous insufficiency ...

Pulse Biosciences, Inc. , a company leveraging its novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced that the U.S.

St. Luke’s cardiac electrophysiology team is first in the Lehigh Valley and Northeastern Pennsylvania to offer pulsed field ablation, a new and improved treatment for atrial fibrillation. This common ...

Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

Citi Annual Global Healthcare Conference 2025 December 3, 2025 11:15 AM ESTCompany ParticipantsMichael Bodner - Global Head ...

The Alabama Supreme Court this week issued a ruling in the case of Sandra Phillips versus Shelby Baptist Medical Center and Dr. Steven M. Taylor. In her complaint, Phillips claims that Taylor left ...

Pulsed field ablation is a minimally invasive procedure to treat atrial fibrillation (AFib) and other arrhythmias. Instead of thermal energy used with traditional ablation techniques (radiofrequency ...

ABSTRACT: Objective: We assessed the mechanism of venous vascular occlusion in the great saphenous vein (GSV) following radiofrequency venous ablation (RFA) in clinical cases of varicose veins.

1 Departments of Cardiovascular Surgery, Amagasaki Central Hospital, Amagasaki, Hyogo, Japan. 2 Departments of Cardiovascular Surgery, Kawachi General Hospital, Hyogo ...

Farapulse has propelled Boston Scientific’s electrophysiology business to triple-digit growth, exceeding the company’s expectations, since the device won FDA approval in early 2024 for people whose ...